￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The latest market price of Datopotamab in 2025

2026-02-01 22:25:32

Check Details
Study on the safe discontinuation method of Mavakatai/Mefantoux

2026-02-01 22:25:32

Check Details
The best time to take tenofovir alafenamide fumarate tablets (Vemlidy)

2026-02-01 22:25:32

Check Details
FDA approves Pegcetacoplan-Empaveli to treat rare kidney disease

2026-02-01 22:25:32

Check Details
The anti-cytomegalovirus mechanism of maribabavir/yitazhi

2026-02-01 22:25:32

Check Details
Is there any generic version of Inavolisib currently available?

2026-02-01 22:25:32

Check Details
What are the common side effects of Datopotamab?

2026-02-01 22:25:32

Check Details
2025 Mavacamten Price Trend Forecast

2026-02-01 22:25:32

Check Details
Comparative analysis of tenofovir alafenamide tablets (Vemlidy) and entecavir

2026-02-01 22:25:32

Check Details
EMA approves cemiplimab as adjuvant treatment for metastatic colorectal cancer with high risk of recurrence

2026-02-01 22:25:32

Check Details
Daprodustat FDA approval time announced

2026-02-01 22:25:32

Check Details
Adjuvant durvalumab plus temsilimumab improves DFS after renal cell carcinoma resection

2026-02-01 22:25:32

Check Details
Category
相关知识